| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
MacLean Michael F is a Chief Financial Officer at Avidity Biosciences, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $836K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sell | 1,974 | $72.23 | $142,582.02 | -3.0% | |
| Aug 6, 2025 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sell | 30,914 | $42.73 | $1,320,843.93 | -32.0% | |
| Mar 20, 2025 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sell | 7,935 | $31.06 | $246,424.60 | -7.6% | |
| Jan 21, 2025 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sell | 3,287 | $28.59 | $93,985.36 | -1.5% | |
| Dec 18, 2024 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sell | 11,151 | $32.66 | $364,191.66 | -11.9% | |
| Nov 6, 2024 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sale+OE | 106,319 | $45.56 | $4,843,979.06 | -27.4% | |
| Sep 23, 2024 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sell | 11,510 | $44.00 | $506,440.00 | -10.7% | |
| Jun 18, 2024 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sell | 11,228 | $39.13 | $439,344.90 | -16.3% | |
| Jun 12, 2024 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sale+OE | 104,245 | $35.72 | $3,723,141.45 | -70.3% | |
| May 14, 2024 | RNA Avidity Biosciences, Inc. | Chief Financial Officer | Sale+OE | 75,000 | $28.28 | $2,121,045.00 | -63.0% |